Peroxiredoxin III protects pancreatic ß cells from apoptosis

Type 1 diabetes mellitus is characterized by a progressive autoimmune destruction of insulin-producing ß cells. Macrophages and T lymphocytes release cytokines, which induce the synthesis of oxygen and nitrogen radicals in the pancreatic islets. The resulting cellular and mitochondrial damage promot...

Full description

Bibliographic Details
Main Authors: Wolf, G., Aumann, N., Michalska, M., Bast, A., Sonnemann, J., Beck, J., Lendeckel, U., Newsholme, Philip, Walther, R.
Format: Journal Article
Published: BioScientifica 2010
Online Access:http://hdl.handle.net/20.500.11937/13012
_version_ 1848748234866950144
author Wolf, G.
Aumann, N.
Michalska, M.
Bast, A.
Sonnemann, J.
Beck, J.
Lendeckel, U.
Newsholme, Philip
Walther, R.
author_facet Wolf, G.
Aumann, N.
Michalska, M.
Bast, A.
Sonnemann, J.
Beck, J.
Lendeckel, U.
Newsholme, Philip
Walther, R.
author_sort Wolf, G.
building Curtin Institutional Repository
collection Online Access
description Type 1 diabetes mellitus is characterized by a progressive autoimmune destruction of insulin-producing ß cells. Macrophages and T lymphocytes release cytokines, which induce the synthesis of oxygen and nitrogen radicals in the pancreatic islets. The resulting cellular and mitochondrial damage promotes ß cell death. ß cells are very sensitive to the autoimmune free radical-dependent attack due to their low content of antioxidant enzymes such as glutathione peroxidase and catalase. A focal point of ß cell protection should be the control of the mitochondrial redox status, which will result in the preservation of metabolic stimulus-secretion coupling. For this reason, there is a considerable interest in the mitochondrial peroxiredoxin III (PRX III), a thioredoxin-dependent peroxide reductase, which was shown to be able to protect against both oxidative and nitrosative stress. Using the Tet-On-system, we generated stably transfected rat insulinoma cells over- or under-expressing PRX III in a doxycyclin-dependent manner to analyze the effect of increased or decreased amounts of cellular PRX III, following treatment with several stressors. We provide evidence that PRX III protects pancreatic ß cells from cell stress induced by accumulation of hydrogen peroxide, or the induction of inducible nitric oxide synthase or caspase-9 and -3 by pro-inflammatory cytokines or streptozotocin. Basal insulin secretion was markedly decreased in cells expressing lower levels of PRX III. We suggest PRX III may be a suitable target for promoting deceleration or even prevention of stress-associated apoptosis in pancreatic ß cells and the manifestation of insulin-dependent diabetes mellitus. © 2010 Society for Endocrinology.
first_indexed 2025-11-14T07:01:49Z
format Journal Article
id curtin-20.500.11937-13012
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:01:49Z
publishDate 2010
publisher BioScientifica
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-130122017-09-13T15:02:12Z Peroxiredoxin III protects pancreatic ß cells from apoptosis Wolf, G. Aumann, N. Michalska, M. Bast, A. Sonnemann, J. Beck, J. Lendeckel, U. Newsholme, Philip Walther, R. Type 1 diabetes mellitus is characterized by a progressive autoimmune destruction of insulin-producing ß cells. Macrophages and T lymphocytes release cytokines, which induce the synthesis of oxygen and nitrogen radicals in the pancreatic islets. The resulting cellular and mitochondrial damage promotes ß cell death. ß cells are very sensitive to the autoimmune free radical-dependent attack due to their low content of antioxidant enzymes such as glutathione peroxidase and catalase. A focal point of ß cell protection should be the control of the mitochondrial redox status, which will result in the preservation of metabolic stimulus-secretion coupling. For this reason, there is a considerable interest in the mitochondrial peroxiredoxin III (PRX III), a thioredoxin-dependent peroxide reductase, which was shown to be able to protect against both oxidative and nitrosative stress. Using the Tet-On-system, we generated stably transfected rat insulinoma cells over- or under-expressing PRX III in a doxycyclin-dependent manner to analyze the effect of increased or decreased amounts of cellular PRX III, following treatment with several stressors. We provide evidence that PRX III protects pancreatic ß cells from cell stress induced by accumulation of hydrogen peroxide, or the induction of inducible nitric oxide synthase or caspase-9 and -3 by pro-inflammatory cytokines or streptozotocin. Basal insulin secretion was markedly decreased in cells expressing lower levels of PRX III. We suggest PRX III may be a suitable target for promoting deceleration or even prevention of stress-associated apoptosis in pancreatic ß cells and the manifestation of insulin-dependent diabetes mellitus. © 2010 Society for Endocrinology. 2010 Journal Article http://hdl.handle.net/20.500.11937/13012 10.1677/JOE-09-0455 BioScientifica unknown
spellingShingle Wolf, G.
Aumann, N.
Michalska, M.
Bast, A.
Sonnemann, J.
Beck, J.
Lendeckel, U.
Newsholme, Philip
Walther, R.
Peroxiredoxin III protects pancreatic ß cells from apoptosis
title Peroxiredoxin III protects pancreatic ß cells from apoptosis
title_full Peroxiredoxin III protects pancreatic ß cells from apoptosis
title_fullStr Peroxiredoxin III protects pancreatic ß cells from apoptosis
title_full_unstemmed Peroxiredoxin III protects pancreatic ß cells from apoptosis
title_short Peroxiredoxin III protects pancreatic ß cells from apoptosis
title_sort peroxiredoxin iii protects pancreatic ß cells from apoptosis
url http://hdl.handle.net/20.500.11937/13012